Kelly Tseng, (Life Sciences) is the with Provectus Biopharmaceuticals, a clinical-stage biotechnology company. The project is to investigate and characterize the effects of Provectus' drug product on vertebrate tissue regeneration and repair.
Kelly Tseng, (Life Sciences) is the with Provectus Biopharmaceuticals, a clinical-stage biotechnology company. The project is to investigate and characterize the effects of Provectus' drug product on vertebrate tissue regeneration and repair.